Fu Y - Search Results

1

LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.

Li W, Lin H, Fu Y, Flarakos J. Li W, et al. Among authors: fu y. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 15;1044-1045:166-176. doi: 10.1016/j.jchromb.2016.12.044. Epub 2017 Jan 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28113139

2

An investigation of incurred human urine sample reanalysis failure.

Fu Y, Li W, Smith HT, Tse FL. Fu Y, et al. Bioanalysis. 2011 May;3(9):967-72. doi: 10.4155/bio.11.65. Bioanalysis. 2011. PMID: 21545344

3

Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay.

Yuan L, Fu Y, Zhang D, Xia YQ, Peng Q, Aubry AF, Arnold ME. Yuan L, et al. Among authors: fu y. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:60-8. doi: 10.1016/j.jchromb.2014.08.006. Epub 2014 Aug 12. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 25151331

4

Quantitative analysis of pasireotide (SOM230), a cyclic peptide, in monkey plasma using liquid chromatography in combination with tandem mass spectrometry.

Fu Y, Li W, Flarakos J, Tse FLS. Fu Y, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:242-249. doi: 10.1016/j.jchromb.2015.11.025. Epub 2015 Dec 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26680325

5

Differential Mobility Spectrometry Coupled with Multiple Ion Monitoring in Regulated LC-MS/MS Bioanalysis of a Therapeutic Cyclic Peptide in Human Plasma.

Fu Y, Xia YQ, Flarakos J, Tse FL, Miller JD, Jones EB, Li W. Fu Y, et al. Anal Chem. 2016 Apr 5;88(7):3655-61. doi: 10.1021/acs.analchem.5b04408. Epub 2016 Mar 18. Anal Chem. 2016. PMID: 26937555

6

Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent, in human dried blood spots using liquid chromatography-tandem mass spectrometry.

Li W, Doherty J, Fu Y, Flarakos J. Li W, et al. Among authors: fu y. Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4068. Epub 2017 Sep 20. Biomed Chromatogr. 2018. PMID: 28833263

7

Highly selective and sensitive LC-MS/MS quantification of a therapeutic protein in human serum using immunoaffinity capture enrichment.

Fu Y, Li W, Flarakos J. Fu Y, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Nov 15;1100-1101:83-90. doi: 10.1016/j.jchromb.2018.09.040. Epub 2018 Oct 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 30296718

8

Recommendations and best practices for calibration curves in quantitative LC-MS bioanalysis.

Fu Y, Li W, Flarakos J. Fu Y, et al. Bioanalysis. 2019 Aug;11(15):1375-1377. doi: 10.4155/bio-2019-0149. Bioanalysis. 2019. PMID: 31490108 No abstract available.

9

Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis.

Fu Y, Barkley D, Li W, Picard F, Flarakos J. Fu Y, et al. Bioanalysis. 2020 Apr;12(8):545-559. doi: 10.4155/bio-2020-0058. Epub 2020 Apr 30. Bioanalysis. 2020. PMID: 32352315 Review.

10

Critical considerations of matrix selection in LC-MS bioanalysis for toxicokinetic and pharmacokinetic assessment in drug development.

Fu Y, Li W, Flarakos J. Fu Y, et al. Bioanalysis. 2021 Apr;13(8):605-608. doi: 10.4155/bio-2020-0319. Epub 2021 Mar 17. Bioanalysis. 2021. PMID: 33728968 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,584 results

Search Page

Filters